Docmode Health Technologies Approves Transfer of 75 Senior Non-Convertible Debentures
Docmode Health Technologies Limited, previously known as Docmode Health Technologies Private Limited, has announced the approval of a significant transfer of its non-convertible debentures (NCDs). The company's Board of Directors approved the proposed sale of 75 Senior, Unlisted, Secured, Redeemable, Non-Convertible Debentures.The board meeting, held on April 20, 2026, concluded the process concerning the transfer from Aquilon Capital Emerging Sectors to Mr. Nikhil Ashok Dike.
According to the approval, Aquilon Capital Emerging Sectors, which is an alternate investment fund of Aquilon Capital Trust, is the seller in this transaction. The debentures are being transferred to Mr. Nikhil Ashok Dike, the buyer.
The aggregate consideration for the transfer of the 75 debentures was confirmed to be Rs. 75,00,000/-.
The transfer was approved by the Board of Directors at 4:15 p.m. on April 20, 2026. The company confirmed that the transfer will be conducted strictly in accordance with the original terms of issue of the debentures and applicable laws.
The key details of the debenture transfer are summarized below:
| Detail | Information |
|---|---|
| Company | Docmode Health Technologies Limited |
| Debentures Transferred | 75 Senior, Unlisted, Secured, Redeemable, Non-Convertible Debentures |
| Seller | Aquilon Capital Emerging Sectors (an alternate investment fund of Aquilon Capital Trust) |
| Buyer | Mr. Nikhil Ashok Dike |
| Aggregate Consideration | Rs. 75,00,000/- |
| Approval Date | April 20, 2026 |
| Approval Time | 04:15 p.m. |
DHTL Stock Price Movement
Today, Docmode Health Technologies Limited shares settled flat at ₹40.00, recording no percentage movement during today’s session. The stock matched its previous day’s closing price of ₹40.00, signaling stable trading activity for the equity.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.